Loading
Kestra Medical Technologies, Ltd. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by COHEN RAYMOND W, was filed 30 Mar 2026.
Insider Decl.
105
Thresholds
n/a
Buy Volume
€968,610
4 ops. · all time
Sell Volume
€10M
46 ops. · all time
Who traded when
BuySaleBrian Daniel Webster19 sales
Traci S. Umberger1 buy7 sales
Mahboob Vaseem7 sales
Ford Alfred J Jr1 buy4 sales
Moran Timothy P.3 sales
Raymond W. Cohen2 buys1 sale
+5 other insiders
Since the insiders bought
- +37.0%Entry US$19.93 · Close 21 Oct 2026 US$27.31
- +3.8%Entry US$23.20 · Close at T+365 US$24.08
- +3.8%Entry US$23.20 · Close at T+365 US$24.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Kestra Medical Technologies, Ltd. Strong Buy (bullish), based on 8 analysts. Average price target: US$30.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,519 of 26,250 companies
29.0
score / 100
Value19
Quality39
FCF yld-7.0%
Earn yld-7.8%
EV/EBITDA·
ROE-74%
Gross mgn51%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended April 2026 · cache
US$28.28
Analyst consensus
8 analystsStrong buy
US$28.00Target US$30.75(+9%)US$34.00
Income statement
RevenueUS$95.1M
Gross profitUS$48.9M51% margin
EBITDA-US$115.1M-121% margin
Net income-US$131.6M-140.4% margin
Valuation
PER (forward)-13.8x
P/Book7.5x
Balance sheet & cash
Market capUS$1.7B
Total debtUS$46.8M
Free Cash Flow-US$117.1M
Debt / Equity34%
Profitability & ownership
ROE-73.7%
ROA-29.2%
% insiders5.2%
% institutions101.8%
Last declaration on 22 October 2026
Declarations105 total
100,000 shares@ US$17.00Common SharesSEC:0001193125-26-428980:0
96,404 shares@ US$27.1493Common SharesSEC:0001193125-26-428980:1
3,596 shares@ US$28.0915Common SharesSEC:0001193125-26-428980:2
13,316 shares@ US$29.5172Common SharesSEC:0001193125-26-428976:0
1,684 shares@ US$29.892Common SharesSEC:0001193125-26-428976:1
100,000 shares@ US$27.18320.16% mcap61.9% of flowCommon StockSEC144:0001964306-26-000473
15,000 shares@ US$29.55920.026% mcap5.8% of flowCommon StockSEC144:0001964306-26-000472
3,330 shares@ US$29.28050.0057% mcap14.0% of flowCommon SharesSEC:0001193125-26-410928:0
3,330 shares@ US$29.28050.0057% mcap16.3% of flowCommon StockSEC144:0001964306-26-000458
4,010 shares@ US$24.25630.0059% mcap50.0% of flowCommon SharesSEC:0001193125-26-399696:0
4,010 shares@ US$24.25630.0059% mcap50.0% of flowCommon StockSEC144:0001964306-26-000452
7,217 sharesCommon SharesSEC:0001193125-26-388306:0
7,217 sharesCommon SharesSEC:0001193125-26-388302:1
7,217 sharesCommon SharesSEC:0000950130-26-000223:1
7,217 sharesCommon SharesSEC:0001193125-26-388297:1
7,217 sharesCommon SharesSEC:0001193125-26-388298:1
7,217 sharesCommon SharesSEC:0001193125-26-388308:0
5,694 shares@ US$25.25090.0082% mcap50.0% of flowCommon SharesSEC:0001193125-26-388302:0
3,890 shares@ US$25.1780.0056% mcap100.0% of flowCommon SharesSEC:0000950130-26-000223:0
3,908 shares@ US$25.19560.0056% mcap50.0% of flowCommon SharesSEC:0001193125-26-388297:0
2,932 shares@ US$25.12870.0042% mcap50.0% of flowCommon SharesSEC:0001193125-26-388298:0
5,694 shares@ US$25.25090.0082% mcap50.0% of flowCommon StockSEC144:0001964306-26-000431
3,890 shares@ US$25.17850.0056% mcap100.0% of flowCommon SharesSEC144:0000950130-26-000219
3,908 shares@ US$25.19560.0056% mcap50.0% of flowCommon StockSEC144:0001964306-26-000429
2,932 shares@ US$25.12870.0042% mcap50.0% of flowCommon StockSEC144:0001964306-26-000430
25 of 105 declarations
About Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. is a US healthcare company valued at USD 1.7 billion, and its filing history is short: 99 filings, nearly all in 2026 (83, against 16 in 2025). The one buying episode is March 7, 2025, when 3 filers bought together for EUR 795,795: Alfred J. Ford Jr. (Chief Commercial Officer) for EUR 315,166, Raymond W. Cohen (Director) for EUR 267,891 and Traci S. Umberger for EUR 212,737.
The rest of the flow runs the other way. The record has 4 purchases worth EUR 968,610 and 42 sales worth EUR 7.2 million (median EUR 120,742), so purchases are 9% of open-market trades. The three largest sales are by Brian Daniel Webster, filed as "See Remarks", with EUR 1,033,235 on August 4, 2026 and EUR 355,835 on August 17, 2026, and by Vaseem Mahboob, Chief Financial Officer, with EUR 578,945 on August 7, 2026.
Read moreShow less
The 22 filers also lodged 24 grants and 29 filings of another kind. Brian Daniel Webster appears most often, with 19 filings of which 17 sales. Over the last twelve months there were 86 filings, with 1 purchase and 42 sales. Insiders hold 5.2% of the capital, and filings come out a median of 2 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
